- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Calyxt (NASDAQ:CLXT), Quotes and News Summary
Calyxt (NASDAQ: CLXT)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.140 | -0.140 | 0.0000 | ||||
| REV | 970.000K | 32.000K | -938.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Calyxt Questions & Answers
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
Other companies in Calyxt’s space includes: Allena Pharma (NASDAQ:ALNA), Midatech Pharma (NASDAQ:MTP), Cyclacel Pharmaceuticals (NASDAQ:CYCC), BioRestorative Therapies (NASDAQ:BRTX) and Protagenic Therapeutics (NASDAQ:PTIX).
The latest price target for Calyxt (NASDAQ: CLXT) was reported by Canaccord Genuity on Friday, March 4, 2022. The analyst firm set a price target for 4.00 expecting CLXT to rise to within 12 months (a possible 1189.91% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3101 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.